Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cekay

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|September 1, 2023
Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLCMichael Cekay, Philipp F Arndt, Rio Dumitrascu, et al.
BMJ Open Respiratory Research|August 23, 2024
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancerMichael Cekay, Philipp F Arndt, Johanna K Franken, et al.
Annals of the American Thoracic Society|March 5, 2025
Echocardiographic Measure of Right Ventricular-pulmonary Arterial Coupling Predicts Survival in Lung CancerZvonimir A Rako, Michael Cekay, Athiththan Yogeswaran, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|September 1, 2023
Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLCMichael Cekay, Philipp F Arndt, Rio Dumitrascu, et al.
BMJ Open Respiratory Research|August 23, 2024
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancerMichael Cekay, Philipp F Arndt, Johanna K Franken, et al.
Annals of the American Thoracic Society|March 5, 2025
Echocardiographic Measure of Right Ventricular-pulmonary Arterial Coupling Predicts Survival in Lung CancerZvonimir A Rako, Michael Cekay, Athiththan Yogeswaran, et al.
Pageof 1